179 related articles for article (PubMed ID: 28217919)
41. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
42. Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.
Luijten RK; Cuppen BV; Bijlsma JW; Derksen RH
Lupus; 2014 Dec; 23(14):1512-6. PubMed ID: 25078055
[TBL] [Abstract][Full Text] [Related]
43. Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study.
Chung WS; Lin CL; Kao CH
Lupus; 2016 Apr; 25(4):382-8. PubMed ID: 26585071
[TBL] [Abstract][Full Text] [Related]
44. Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study.
Chung MK; Park JS; Lim H; Lee CH; Lee J
Lupus; 2021 Apr; 30(4):674-679. PubMed ID: 33460342
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study.
Singh JA; Cleveland JD
Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1544-1551. PubMed ID: 32526087
[TBL] [Abstract][Full Text] [Related]
46. Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients.
Barbhaiya M; Feldman CH; Chen SK; Guan H; Fischer MA; Everett BM; Costenbader KH
Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1431-1439. PubMed ID: 32475049
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland.
Helve T
Scand J Rheumatol; 1985; 14(1):43-6. PubMed ID: 4001877
[TBL] [Abstract][Full Text] [Related]
49. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
[TBL] [Abstract][Full Text] [Related]
50. Hospitalization and Mortality Due to Infection Among Children and Adolescents With Systemic Lupus Erythematosus in the United States.
Roberts JE; Faino A; Bryan MA; Cogen JD; Morgan EM
J Rheumatol; 2024 Jun; ():. PubMed ID: 38561187
[TBL] [Abstract][Full Text] [Related]
51. Disease Outcomes and Care Fragmentation Among Patients With Systemic Lupus Erythematosus.
Walunas TL; Jackson KL; Chung AH; Mancera-Cuevas KA; Erickson DL; Ramsey-Goldman R; Kho A
Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1369-1376. PubMed ID: 27899012
[TBL] [Abstract][Full Text] [Related]
52. Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement.
Tanzer M; Tran C; Messer KL; Kroeker A; Herreshoff E; Wickman L; Harkness C; Song P; Gipson DS
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):382-90. PubMed ID: 22899662
[TBL] [Abstract][Full Text] [Related]
53. Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: a nationwide population-based study.
Bae EH; Lim SY; Han KD; Jung JH; Choi HS; Kim HY; Kim CS; Ma SK; Kim SW
Korean J Intern Med; 2020 May; 35(3):652-661. PubMed ID: 31212409
[TBL] [Abstract][Full Text] [Related]
54. The prevalence and incidence of systemic lupus erythematosus in children and adults: a population-based study in a mountain community in northern Italy.
Tsioni V; Andreoli L; Meini A; Frassi M; Raffetti E; Airò P; Allegri F; Donato F; Tincani A
Clin Exp Rheumatol; 2015; 33(5):681-7. PubMed ID: 26089119
[TBL] [Abstract][Full Text] [Related]
55. Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries.
Lieber SB; Nahid M; Navarro-Millán I; Rajan M; Sattui SE; Mandl LA
Lupus Sci Med; 2023 Jul; 10(2):. PubMed ID: 37524516
[TBL] [Abstract][Full Text] [Related]
56. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.
Uramoto KM; Michet CJ; Thumboo J; Sunku J; O'Fallon WM; Gabriel SE
Arthritis Rheum; 1999 Jan; 42(1):46-50. PubMed ID: 9920013
[TBL] [Abstract][Full Text] [Related]
57. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
58. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
Ward MM
J Rheumatol; 2002 Jun; 29(6):1198-206. PubMed ID: 12064835
[TBL] [Abstract][Full Text] [Related]
59. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
60. Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient Sample.
Dhital R; Guma M; Poudel DR; Chambers C; Kalunian K
Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37019477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
